| Name |
Number of publications
|
Most recent publication
|
Publications by all authors
|
Why?
|
|---|
B-Lymphocytes | 14 | 1985 | 134 |
Why?
|
Hematopoietic Stem Cells | 12 | 1985 | 69 |
Why?
|
Bone Marrow | 13 | 1984 | 109 |
Why?
|
Myocardial Infarction | 9 | 2005 | 129 |
Why?
|
Antigens, CD | 12 | 1991 | 128 |
Why?
|
Bone Marrow Cells | 14 | 1985 | 92 |
Why?
|
Hematopoiesis | 6 | 1986 | 47 |
Why?
|
Receptors, Very Late Antigen | 5 | 1991 | 2 |
Why?
|
Cooperative Behavior | 1 | 2011 | 70 |
Why?
|
Cell Adhesion Molecules | 4 | 1991 | 48 |
Why?
|
Interleukin-7 | 3 | 1994 | 6 |
Why?
|
Factor V | 2 | 1998 | 12 |
Why?
|
Polymorphism, Genetic | 8 | 1987 | 94 |
Why?
|
Clinical Trials as Topic | 1 | 2011 | 251 |
Why?
|
Point Mutation | 3 | 1998 | 122 |
Why?
|
B-Lymphocyte Subsets | 3 | 1997 | 33 |
Why?
|
Leukemia | 4 | 1988 | 70 |
Why?
|
Humans | 75 | 1984 | 1856 |
Why?
|
Coronary Artery Disease | 3 | 2005 | 56 |
Why?
|
Genotype | 10 | 1998 | 175 |
Why?
|
Genetic Predisposition to Disease | 7 | 2003 | 131 |
Why?
|
Heterozygote Detection | 1 | 2000 | 16 |
Why?
|
Cytokines | 3 | 1988 | 207 |
Why?
|
Antigens, Neoplasm | 6 | 1984 | 56 |
Why?
|
Receptors, Fc | 9 | 1986 | 28 |
Why?
|
Leukemia, Lymphoid | 4 | 1984 | 22 |
Why?
|
Genome, Human | 1 | 1999 | 29 |
Why?
|
Lymphocyte Activation | 4 | 1987 | 137 |
Why?
|
DNA Probes | 1 | 1999 | 61 |
Why?
|
Biological Assay | 1 | 1999 | 58 |
Why?
|
Heterozygote | 4 | 2003 | 80 |
Why?
|
Cell Adhesion | 9 | 1988 | 113 |
Why?
|
Arthroplasty, Replacement, Knee | 1 | 1998 | 10 |
Why?
|
Arthroplasty, Replacement, Hip | 1 | 1998 | 19 |
Why?
|
Thrombophlebitis | 1 | 1998 | 23 |
Why?
|
Coronary Disease | 1 | 2000 | 94 |
Why?
|
Receptors, Interleukin | 1 | 1997 | 10 |
Why?
|
Stromal Cells | 1 | 1997 | 41 |
Why?
|
Antibodies, Monoclonal | 17 | 1985 | 241 |
Why?
|
Mutation | 2 | 1999 | 340 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2007 | 39 |
Why?
|
Obesity | 3 | 2000 | 149 |
Why?
|
Flow Cytometry | 9 | 1984 | 216 |
Why?
|
Middle Aged | 18 | 1989 | 1161 |
Why?
|
Transforming Growth Factor beta | 1 | 1997 | 99 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 1990 | 28 |
Why?
|
Hospitals | 1 | 1994 | 46 |
Why?
|
Cells, Cultured | 11 | 1987 | 447 |
Why?
|
Postoperative Complications | 1 | 1998 | 305 |
Why?
|
Lymphocytes | 1 | 1994 | 142 |
Why?
|
Proportional Hazards Models | 5 | 2000 | 123 |
Why?
|
Multicenter Studies as Topic | 2 | 2005 | 70 |
Why?
|
Risk Factors | 8 | 1992 | 555 |
Why?
|
Dementia | 1 | 1994 | 56 |
Why?
|
Aged | 18 | 1986 | 988 |
Why?
|
Burkitt Lymphoma | 1 | 1993 | 36 |
Why?
|
Female | 25 | 1985 | 1643 |
Why?
|
Hemochromatosis | 2 | 2002 | 8 |
Why?
|
Cell Differentiation | 7 | 1991 | 262 |
Why?
|
Male | 22 | 1986 | 1553 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2002 | 32 |
Why?
|
Phenotype | 7 | 1987 | 303 |
Why?
|
Antigens, Differentiation | 6 | 1988 | 53 |
Why?
|
Potassium Channels | 2 | 2003 | 33 |
Why?
|
Age of Onset | 2 | 2007 | 64 |
Why?
|
Hypertension | 2 | 2002 | 161 |
Why?
|
DNA Nucleotidylexotransferase | 3 | 1992 | 11 |
Why?
|
Adult | 16 | 1984 | 1317 |
Why?
|
Clinical Laboratory Techniques | 2 | 1984 | 31 |
Why?
|
Recurrence | 6 | 2005 | 261 |
Why?
|
Antigens, CD34 | 6 | 1989 | 26 |
Why?
|
Prospective Studies | 6 | 1990 | 545 |
Why?
|
Membrane Proteins | 3 | 2000 | 233 |
Why?
|
African Continental Ancestry Group | 2 | 2006 | 80 |
Why?
|
Tumor Markers, Biological | 2 | 1988 | 112 |
Why?
|
Fibroblasts | 6 | 1986 | 179 |
Why?
|
Lipase | 1 | 2008 | 11 |
Why?
|
Apolipoprotein A-I | 1 | 2008 | 19 |
Why?
|
Long QT Syndrome | 2 | 2003 | 35 |
Why?
|
Lipoprotein(a) | 1 | 2008 | 12 |
Why?
|
Lipids | 3 | 2000 | 97 |
Why?
|
European Continental Ancestry Group | 2 | 2006 | 117 |
Why?
|
Acridine Orange | 1 | 1988 | 8 |
Why?
|
Immunoglobulin G | 8 | 1985 | 191 |
Why?
|
Fibronectins | 4 | 1990 | 57 |
Why?
|
Bone Marrow Transplantation | 3 | 1988 | 90 |
Why?
|
HLA Antigens | 2 | 1987 | 38 |
Why?
|
Plasminogen Activator Inhibitor 1 | 1 | 2007 | 26 |
Why?
|
Cholesterol Ester Transfer Proteins | 1 | 2007 | 9 |
Why?
|
Aryldialkylphosphatase | 1 | 2007 | 6 |
Why?
|
Hydroxyquinolines | 2 | 1993 | 5 |
Why?
|
Platelet Glycoprotein GPIb-IX Complex | 1 | 2007 | 5 |
Why?
|
Integrins | 4 | 1992 | 35 |
Why?
|
Hypertriglyceridemia | 1 | 2007 | 14 |
Why?
|
Sepsis | 1 | 1988 | 73 |
Why?
|
Diabetic Angiopathies | 1 | 2007 | 24 |
Why?
|
Angiotensinogen | 1 | 2006 | 8 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 1987 | 38 |
Why?
|
Cohort Studies | 5 | 2005 | 332 |
Why?
|
NADPH Oxidase | 1 | 2007 | 21 |
Why?
|
Phospholipases A | 1 | 2007 | 24 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2007 | 31 |
Why?
|
Biological Markers | 3 | 2000 | 262 |
Why?
|
Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 2 | 1993 | 26 |
Why?
|
Cholesterol, HDL | 1 | 2007 | 26 |
Why?
|
Lipoproteins | 1 | 2007 | 52 |
Why?
|
Macrophages | 4 | 1990 | 148 |
Why?
|
Neuroblastoma | 4 | 1985 | 36 |
Why?
|
Chromatography, High Pressure Liquid | 2 | 2003 | 121 |
Why?
|
Extracellular Matrix | 3 | 1989 | 79 |
Why?
|
Angina, Unstable | 1 | 2005 | 20 |
Why?
|
Receptors, Fibronectin | 3 | 1992 | 8 |
Why?
|
Continental Population Groups | 2 | 2002 | 85 |
Why?
|
Stem Cells | 4 | 1986 | 107 |
Why?
|
Cell Division | 3 | 1991 | 273 |
Why?
|
Heart Diseases | 2 | 2002 | 92 |
Why?
|
Hematopoietic Cell Growth Factors | 2 | 1994 | 9 |
Why?
|
Monocytes | 6 | 1986 | 124 |
Why?
|
Clone Cells | 3 | 1987 | 92 |
Why?
|
Genes, Recessive | 1 | 2003 | 33 |
Why?
|
Cell Movement | 3 | 1993 | 163 |
Why?
|
Plasma Cells | 1 | 2003 | 21 |
Why?
|
Survival Analysis | 4 | 1999 | 205 |
Why?
|
Smoking | 1 | 2007 | 153 |
Why?
|
Cytotoxicity, Immunologic | 3 | 1986 | 54 |
Why?
|
Potassium Channels, Voltage-Gated | 1 | 2003 | 17 |
Why?
|
Immediate-Early Proteins | 1 | 2003 | 18 |
Why?
|
Melanocytes | 2 | 1992 | 12 |
Why?
|
Sex | 1 | 2002 | 6 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 1991 | 27 |
Why?
|
Neoplasm Proteins | 2 | 1988 | 110 |
Why?
|
Reference Values | 4 | 1984 | 278 |
Why?
|
Cardiovascular Diseases | 1 | 2006 | 127 |
Why?
|
Sodium Channels | 1 | 2003 | 32 |
Why?
|
Social Class | 1 | 2002 | 46 |
Why?
|
Germinal Center | 2 | 1997 | 14 |
Why?
|
Statistics as Topic | 2 | 1998 | 133 |
Why?
|
Hypercholesterolemia | 1 | 2002 | 33 |
Why?
|
Immunoglobulin Variable Region | 1 | 2001 | 22 |
Why?
|
Osteoarthritis | 1 | 2003 | 51 |
Why?
|
Immunoglobulin Heavy Chains | 1 | 2001 | 24 |
Why?
|
Mutation, Missense | 1 | 2002 | 59 |
Why?
|
Diabetes Mellitus | 1 | 2002 | 72 |
Why?
|
Sensitivity and Specificity | 2 | 1999 | 427 |
Why?
|
Sex Distribution | 2 | 1994 | 101 |
Why?
|
Genetic Testing | 3 | 2003 | 49 |
Why?
|
Apolipoproteins A | 1 | 2000 | 9 |
Why?
|
Immune Tolerance | 1 | 2001 | 72 |
Why?
|
Skin | 2 | 1993 | 177 |
Why?
|
Age Distribution | 2 | 1994 | 127 |
Why?
|
Blood Coagulation | 1 | 2000 | 57 |
Why?
|
Tumor Stem Cell Assay | 2 | 1988 | 21 |
Why?
|
Immunologic Memory | 2 | 1997 | 51 |
Why?
|
Body Composition | 1 | 2000 | 44 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2000 | 16 |
Why?
|
Regression Analysis | 3 | 2000 | 256 |
Why?
|
Adipose Tissue | 1 | 2000 | 80 |
Why?
|
Prostaglandins | 1 | 2000 | 41 |
Why?
|
Body Mass Index | 1 | 2000 | 122 |
Why?
|
Immunophenotyping | 2 | 1993 | 66 |
Why?
|
Antineoplastic Agents | 2 | 1988 | 190 |
Why?
|
Neoplastic Stem Cells | 1 | 2000 | 21 |
Why?
|
Transcription, Genetic | 1 | 2003 | 253 |
Why?
|
Incidence | 2 | 1994 | 336 |
Why?
|
Aged, 80 and over | 4 | 1992 | 599 |
Why?
|
Phlebography | 1 | 1998 | 28 |
Why?
|
Antibodies | 3 | 1992 | 159 |
Why?
|
Prostaglandin-Endoperoxide Synthases | 1 | 2000 | 66 |
Why?
|
Antibodies, Neoplasm | 2 | 1988 | 28 |
Why?
|
Superoxides | 3 | 1985 | 36 |
Why?
|
Stem Cell Factor | 2 | 1994 | 13 |
Why?
|
Tetradecanoylphorbol Acetate | 2 | 1991 | 83 |
Why?
|
Receptors, Interleukin-7 | 1 | 1997 | 4 |
Why?
|
Antigens, CD19 | 1 | 1997 | 9 |
Why?
|
Genetic Markers | 3 | 1986 | 78 |
Why?
|
Fibrinolytic Agents | 1 | 1998 | 42 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 1997 | 15 |
Why?
|
Telomerase | 1 | 1997 | 15 |
Why?
|
Antigens, CD45 | 1 | 1997 | 30 |
Why?
|
Prognosis | 1 | 2000 | 388 |
Why?
|
Follow-Up Studies | 3 | 2005 | 553 |
Why?
|
C-Reactive Protein | 2 | 2007 | 54 |
Why?
|
Isoenzymes | 1 | 2000 | 144 |
Why?
|
Neprilysin | 2 | 1984 | 4 |
Why?
|
Chromosomes, Human, 6-12 and X | 2 | 1986 | 7 |
Why?
|
Multivariate Analysis | 2 | 2007 | 225 |
Why?
|
Colony-Forming Units Assay | 2 | 1991 | 27 |
Why?
|
Granulocytes | 3 | 1989 | 46 |
Why?
|
Receptors, IgG | 7 | 1986 | 30 |
Why?
|
Acute Disease | 2 | 1987 | 271 |
Why?
|
Receptors, Lymphocyte Homing | 1 | 1995 | 10 |
Why?
|
Combined Modality Therapy | 3 | 1988 | 219 |
Why?
|
Probability | 2 | 2005 | 190 |
Why?
|
Integrin alpha4beta1 | 1 | 1995 | 6 |
Why?
|
Up-Regulation | 1 | 1997 | 183 |
Why?
|
Blood Platelets | 2 | 1987 | 67 |
Why?
|
Cross-Sectional Studies | 3 | 2000 | 253 |
Why?
|
Gene Frequency | 2 | 2002 | 42 |
Why?
|
Pulmonary Alveoli | 3 | 1990 | 80 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 2 | 1991 | 53 |
Why?
|
Medical Record Linkage | 1 | 1994 | 4 |
Why?
|
Scotland | 1 | 1994 | 9 |
Why?
|
DNA | 1 | 1999 | 262 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 1997 | 119 |
Why?
|
Neutrophils | 2 | 1985 | 114 |
Why?
|
Fluorescent Antibody Technique | 4 | 1984 | 164 |
Why?
|
Cell Separation | 1 | 1994 | 110 |
Why?
|
Patient Admission | 1 | 1994 | 72 |
Why?
|
Polymorphism, Single-Stranded Conformational | 2 | 2003 | 23 |
Why?
|
Interleukin-4 | 1 | 1994 | 62 |
Why?
|
Interleukin-1 | 1 | 1994 | 109 |
Why?
|
Severity of Illness Index | 2 | 2005 | 358 |
Why?
|
Membrane Glycoproteins | 2 | 1991 | 154 |
Why?
|
Adjuvants, Immunologic | 1 | 1993 | 73 |
Why?
|
Palatine Tonsil | 3 | 1985 | 20 |
Why?
|
DNA Mutational Analysis | 2 | 2002 | 110 |
Why?
|
Risk Assessment | 2 | 2005 | 324 |
Why?
|
Spinal Fusion | 1 | 1992 | 24 |
Why?
|
Inflammation | 3 | 1987 | 208 |
Why?
|
Mice | 5 | 1985 | 623 |
Why?
|
Intercellular Adhesion Molecule-1 | 1 | 1993 | 51 |
Why?
|
Reproducibility of Results | 2 | 2003 | 391 |
Why?
|
Lymphocyte Function-Associated Antigen-1 | 1 | 1991 | 10 |
Why?
|
Macrophage Colony-Stimulating Factor | 1 | 1991 | 17 |
Why?
|
Leukemia, Myeloid, Acute | 3 | 1986 | 53 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 1991 | 34 |
Why?
|
Bacterial Infections | 1 | 1992 | 88 |
Why?
|
Plastics | 1 | 1990 | 11 |
Why?
|
Blood Transfusion | 1 | 1992 | 59 |
Why?
|
Adolescent | 4 | 1988 | 891 |
Why?
|
Polymerase Chain Reaction | 2 | 2003 | 279 |
Why?
|
Gene Rearrangement, gamma-Chain T-Cell Antigen Receptor | 1 | 1990 | 2 |
Why?
|
Prevalence | 2 | 2002 | 281 |
Why?
|
Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor | 1 | 1990 | 3 |
Why?
|
Gene Rearrangement, beta-Chain T-Cell Antigen Receptor | 1 | 1990 | 10 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 1990 | 11 |
Why?
|
Nervous System | 1 | 1990 | 52 |
Why?
|
Asparaginase | 1 | 1989 | 3 |
Why?
|
Killer Cells, Natural | 2 | 1986 | 62 |
Why?
|
Gene Rearrangement, B-Lymphocyte | 1 | 1989 | 13 |
Why?
|
Cryoglobulinemia | 1 | 1989 | 7 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 1994 | 210 |
Why?
|
Base Sequence | 1 | 1994 | 371 |
Why?
|
Genes, Immunoglobulin | 1 | 1989 | 28 |
Why?
|
Translocation, Genetic | 2 | 1986 | 35 |
Why?
|
Multiple Sclerosis | 1 | 1990 | 43 |
Why?
|
Virus Replication | 1 | 1991 | 90 |
Why?
|
Angina Pectoris | 1 | 2008 | 31 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 1989 | 33 |
Why?
|
Molecular Sequence Data | 1 | 1994 | 404 |
Why?
|
Pregnancy Complications | 1 | 1990 | 98 |
Why?
|
Colony-Stimulating Factors | 1 | 1988 | 13 |
Why?
|
Aneuploidy | 1 | 1988 | 15 |
Why?
|
Leukemia, Experimental | 1 | 1988 | 20 |
Why?
|
Kaplan-Meier Estimate | 1 | 2008 | 89 |
Why?
|
Biological Agents | 1 | 1988 | 15 |
Why?
|
RNA, Neoplasm | 1 | 1988 | 41 |
Why?
|
Transferases | 1 | 1987 | 7 |
Why?
|
Immunologic Tests | 1 | 1987 | 2 |
Why?
|
Lymphocyte Culture Test, Mixed | 1 | 1987 | 21 |
Why?
|
Blood | 1 | 1988 | 67 |
Why?
|
Tumor Cells, Cultured | 3 | 1989 | 233 |
Why?
|
DNA, Neoplasm | 1 | 1988 | 75 |
Why?
|
HLA-D Antigens | 1 | 1987 | 7 |
Why?
|
Staining and Labeling | 1 | 1988 | 101 |
Why?
|
Remission Induction | 1 | 1988 | 64 |
Why?
|
Antibody-Dependent Cell Cytotoxicity | 4 | 1985 | 14 |
Why?
|
Drug Resistance | 1 | 1988 | 83 |
Why?
|
Haemophilus Infections | 1 | 1988 | 30 |
Why?
|
Phospholipases A2 | 1 | 2007 | 16 |
Why?
|
Models, Biological | 1 | 1993 | 410 |
Why?
|
Leukemia, Myeloid | 1 | 1988 | 37 |
Why?
|
Endothelium | 1 | 1986 | 38 |
Why?
|
Aspartic Acid | 1 | 2007 | 37 |
Why?
|
Glutamine | 1 | 2007 | 27 |
Why?
|
Threonine | 1 | 2006 | 27 |
Why?
|
Blood Glucose | 1 | 2008 | 99 |
Why?
|
Phagocytes | 1 | 1986 | 19 |
Why?
|
Molecular Weight | 4 | 1986 | 154 |
Why?
|
Complement Activation | 1 | 1986 | 13 |
Why?
|
Methionine | 1 | 2006 | 38 |
Why?
|
Nephrectomy | 1 | 1987 | 36 |
Why?
|
Transplantation, Autologous | 2 | 1993 | 78 |
Why?
|
Chromosomes, Human, 16-18 | 1 | 1986 | 2 |
Why?
|
Homozygote | 1 | 2006 | 68 |
Why?
|
Transferrin | 1 | 1986 | 22 |
Why?
|
Arginine | 1 | 2007 | 57 |
Why?
|
Chromosomes, Human, 1-3 | 1 | 1986 | 3 |
Why?
|
Wegener Granulomatosis | 1 | 1986 | 3 |
Why?
|
Amino Acid Substitution | 1 | 2007 | 68 |
Why?
|
Glutamic Acid | 1 | 2007 | 66 |
Why?
|
Cholesterol | 1 | 2007 | 86 |
Why?
|
Philadelphia Chromosome | 1 | 1986 | 11 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2006 | 34 |
Why?
|
Fibrin | 1 | 1986 | 23 |
Why?
|
Zymosan | 1 | 1985 | 11 |
Why?
|
Bone Neoplasms | 1 | 1988 | 83 |
Why?
|
Animals | 5 | 1985 | 1031 |
Why?
|
Graft Rejection | 1 | 1987 | 59 |
Why?
|
Cell Line | 5 | 1986 | 375 |
Why?
|
Chromosome Aberrations | 1 | 1986 | 45 |
Why?
|
Case-Control Studies | 1 | 2007 | 283 |
Why?
|
Fibrinogen | 1 | 1986 | 45 |
Why?
|
Kidney Transplantation | 1 | 1987 | 66 |
Why?
|
Insulin | 1 | 2008 | 129 |
Why?
|
Cyclophosphamide | 1 | 1986 | 82 |
Why?
|
Analysis of Variance | 1 | 2007 | 339 |
Why?
|
Heparin | 1 | 1986 | 87 |
Why?
|
HIV-1 | 1 | 1991 | 93 |
Why?
|
Adenosine Triphosphatases | 1 | 1985 | 43 |
Why?
|
Young Adult | 1 | 2008 | 380 |
Why?
|
Receptors, Cell Surface | 1 | 1986 | 115 |
Why?
|
Myelodysplastic Syndromes | 1 | 1986 | 27 |
Why?
|
Child, Preschool | 2 | 1985 | 554 |
Why?
|
KCNQ Potassium Channels | 1 | 2003 | 9 |
Why?
|
Leukocyte Count | 3 | 1985 | 94 |
Why?
|
Early Growth Response Protein 1 | 1 | 2003 | 10 |
Why?
|
Protein Phosphatase 2 | 1 | 2003 | 15 |
Why?
|
Diseases in Twins | 1 | 2003 | 30 |
Why?
|
Lectins, C-Type | 1 | 2003 | 19 |
Why?
|
Antigens, Differentiation, T-Lymphocyte | 1 | 2003 | 23 |
Why?
|
Chondrocalcinosis | 1 | 2003 | 4 |
Why?
|
Nucleic Acid Denaturation | 1 | 2003 | 21 |
Why?
|
Family Health | 1 | 2003 | 69 |
Why?
|
Pedigree | 1 | 2003 | 84 |
Why?
|
KCNQ1 Potassium Channel | 1 | 2003 | 13 |
Why?
|
Protein Tyrosine Phosphatases | 1 | 2003 | 27 |
Why?
|
Oxidative Stress | 1 | 2007 | 119 |
Why?
|
Exons | 1 | 2003 | 91 |
Why?
|
Australia | 1 | 2002 | 27 |
Why?
|
Introns | 1 | 2003 | 58 |
Why?
|
Sequence Analysis, DNA | 1 | 2003 | 110 |
Why?
|
Ferritins | 1 | 2002 | 36 |
Why?
|
Hand | 1 | 2003 | 37 |
Why?
|
Nutrition Surveys | 1 | 2002 | 36 |
Why?
|
Liver Cirrhosis | 1 | 2002 | 48 |
Why?
|
Interleukin-3 | 2 | 1991 | 19 |
Why?
|
Antigen-Antibody Complex | 3 | 1986 | 34 |
Why?
|
Infant | 1 | 1988 | 464 |
Why?
|
Cell Survival | 3 | 1985 | 229 |
Why?
|
Odds Ratio | 1 | 2002 | 157 |
Why?
|
Time Factors | 2 | 1992 | 896 |
Why?
|
Heart | 1 | 2003 | 88 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2003 | 135 |
Why?
|
Body Constitution | 1 | 2000 | 10 |
Why?
|
Electric Impedance | 1 | 2000 | 14 |
Why?
|
Comorbidity | 1 | 2002 | 190 |
Why?
|
Lupus Erythematosus, Systemic | 1 | 2001 | 52 |
Why?
|
Gene Expression Profiling | 1 | 2003 | 138 |
Why?
|
Sex Factors | 1 | 2002 | 284 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2003 | 243 |
Why?
|
Antibodies, Anti-Idiotypic | 1 | 2000 | 35 |
Why?
|
Cyclooxygenase 1 | 1 | 2000 | 41 |
Why?
|
Enzyme Induction | 1 | 2000 | 64 |
Why?
|
CD40 Ligand | 1 | 2000 | 51 |
Why?
|
Th2 Cells | 1 | 2000 | 36 |
Why?
|
Health Status | 1 | 2001 | 127 |
Why?
|
Transplantation, Homologous | 2 | 1987 | 94 |
Why?
|
Hybridomas | 2 | 1986 | 31 |
Why?
|
Lipopolysaccharides | 1 | 2000 | 98 |
Why?
|
Cyclooxygenase 2 | 1 | 2000 | 77 |
Why?
|
Dinoprostone | 1 | 2000 | 55 |
Why?
|
Isoelectric Focusing | 2 | 1986 | 18 |
Why?
|
Immunity, Cellular | 2 | 1986 | 85 |
Why?
|
Platelet Aggregation | 2 | 1987 | 33 |
Why?
|
ADP-ribosyl Cyclase | 1 | 1997 | 6 |
Why?
|
Antigens, CD38 | 1 | 1997 | 7 |
Why?
|
N-Glycosyl Hydrolases | 1 | 1997 | 5 |
Why?
|
Immunoglobulin D | 1 | 1997 | 10 |
Why?
|
Patient Selection | 1 | 1999 | 155 |
Why?
|
Interphase | 1 | 1997 | 26 |
Why?
|
DNA-Binding Proteins | 1 | 2003 | 204 |
Why?
|
Interferon-gamma | 1 | 2000 | 133 |
Why?
|
Primary Health Care | 1 | 2002 | 151 |
Why?
|
Transcription Factors | 1 | 2003 | 201 |
Why?
|
Child | 3 | 1985 | 749 |
Why?
|
Binding Sites, Antibody | 2 | 1985 | 28 |
Why?
|
Chromosome Banding | 2 | 1986 | 15 |
Why?
|
Karyotyping | 2 | 1986 | 47 |
Why?
|
Kinetics | 2 | 1985 | 349 |
Why?
|
Gene Expression Regulation | 2 | 1987 | 277 |
Why?
|
Immunomagnetic Separation | 1 | 1994 | 6 |
Why?
|
Chromatography, Affinity | 1 | 1994 | 49 |
Why?
|
United States | 1 | 2002 | 604 |
Why?
|
Laminin | 1 | 1994 | 40 |
Why?
|
Dose-Response Relationship, Drug | 2 | 1985 | 431 |
Why?
|
Mice, Inbred BALB C | 2 | 1985 | 176 |
Why?
|
Leukemia, Monocytic, Acute | 1 | 1993 | 10 |
Why?
|
Gestational Age | 1 | 1994 | 114 |
Why?
|
Ligands | 1 | 1994 | 116 |
Why?
|
Oligopeptides | 1 | 1992 | 56 |
Why?
|
T-Lymphocytes | 2 | 1985 | 182 |
Why?
|
Collagen | 1 | 1994 | 118 |
Why?
|
Phenanthrolines | 1 | 1991 | 7 |
Why?
|
Phosphatidylinositol Diacylglycerol-Lyase | 1 | 1991 | 10 |
Why?
|
RNA, Messenger | 1 | 2000 | 394 |
Why?
|
Phosphoinositide Phospholipase C | 1 | 1991 | 9 |
Why?
|
Phosphoric Diester Hydrolases | 1 | 1991 | 29 |
Why?
|
Precipitin Tests | 1 | 1991 | 81 |
Why?
|
Cross Infection | 1 | 1992 | 46 |
Why?
|
Immune System | 1 | 1992 | 43 |
Why?
|
Cross-Linking Reagents | 1 | 1991 | 38 |
Why?
|
Drug Synergism | 1 | 1991 | 104 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 1991 | 167 |
Why?
|
Peritoneal Cavity | 1 | 1990 | 28 |
Why?
|
Opsonin Proteins | 1 | 1990 | 12 |
Why?
|
Immunoglobulin mu-Chains | 1 | 1990 | 10 |
Why?
|
Neurologic Examination | 1 | 1990 | 64 |
Why?
|
Immunoglobulin kappa-Chains | 1 | 1990 | 14 |
Why?
|
Gene Rearrangement | 1 | 1990 | 26 |
Why?
|
Blotting, Southern | 1 | 1990 | 69 |
Why?
|
T-Lymphocytes, Regulatory | 1 | 1990 | 32 |
Why?
|
DNA Replication | 1 | 1991 | 75 |
Why?
|
Cell Compartmentation | 1 | 1989 | 37 |
Why?
|
Binding Sites | 1 | 1991 | 213 |
Why?
|
Infant, Newborn | 1 | 1994 | 389 |
Why?
|
Erythrocytes | 1 | 1990 | 109 |
Why?
|
Interleukin-6 | 1 | 1991 | 145 |
Why?
|
Phycoerythrin | 1 | 1988 | 6 |
Why?
|
Cycloheximide | 1 | 1988 | 51 |
Why?
|
Structure-Activity Relationship | 1 | 1988 | 124 |
Why?
|
Culture Media | 1 | 1988 | 116 |
Why?
|
Isoelectric Point | 1 | 1987 | 14 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 1990 | 113 |
Why?
|
Receptors, Interleukin-2 | 1 | 1987 | 31 |
Why?
|
Batroxobin | 1 | 1986 | 2 |
Why?
|
Blood Protein Electrophoresis | 1 | 1986 | 13 |
Why?
|
Latex Fixation Tests | 1 | 1986 | 15 |
Why?
|
Neoplasm Metastasis | 1 | 1988 | 112 |
Why?
|
Protamines | 1 | 1986 | 15 |
Why?
|
Partial Thromboplastin Time | 1 | 1986 | 15 |
Why?
|
Electrophoresis, Agar Gel | 1 | 1986 | 27 |
Why?
|
Antigens, Surface | 1 | 1987 | 51 |
Why?
|
Receptors, Transferrin | 1 | 1986 | 14 |
Why?
|
Leukemia, Erythroblastic, Acute | 1 | 1986 | 15 |
Why?
|
False Positive Reactions | 1 | 1986 | 71 |
Why?
|
Genes | 1 | 1987 | 82 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 1986 | 16 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 1986 | 37 |
Why?
|
Rosette Formation | 1 | 1986 | 13 |
Why?
|
Fluorescence | 1 | 1986 | 46 |
Why?
|
Genetic Variation | 1 | 1987 | 91 |
Why?
|
Endocytosis | 1 | 1986 | 38 |
Why?
|
Immunoglobulin Fab Fragments | 1 | 1986 | 23 |
Why?
|
Eosinophils | 1 | 1986 | 30 |
Why?
|
Nitroblue Tetrazolium | 1 | 1985 | 4 |
Why?
|
Binding, Competitive | 1 | 1986 | 109 |
Why?
|
Ca(2+) Mg(2+)-ATPase | 1 | 1985 | 11 |
Why?
|
Carcinoma, Hepatocellular | 1 | 1986 | 53 |
Why?
|
Cytoplasmic Granules | 1 | 1985 | 30 |
Why?
|
Nucleotides | 1 | 1985 | 22 |
Why?
|
Hydrolysis | 1 | 1985 | 57 |
Why?
|
Myeloma Proteins | 1 | 1985 | 5 |
Why?
|
Liver Neoplasms | 1 | 1986 | 97 |
Why?
|
Magnesium | 1 | 1985 | 69 |
Why?
|
Recombinant Proteins | 1 | 1988 | 290 |
Why?
|
Pregnancy | 1 | 1990 | 455 |
Why?
|
Complement System Proteins | 1 | 1985 | 30 |
Why?
|
Membrane Potentials | 1 | 1985 | 99 |
Why?
|
Immunoenzyme Techniques | 1 | 1985 | 125 |
Why?
|
Immunohistochemistry | 1 | 1988 | 355 |
Why?
|
Enzyme Activation | 1 | 1985 | 177 |
Why?
|
Adenosine Triphosphate | 1 | 1985 | 121 |
Why?
|
